Researchers at Maastricht UMC+ have successfully tested a novel drug that blocks toxin accumulation in patients with hereditary fructose intolerance, potentially eliminating the need for strict dietary restrictions.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.